Seeing Is Believing
Currently out of the existing stock ratings of Gabrielle Zhou, 6 are a BUY (85.71%), 1 are a HOLD (14.29%).
Analyst Gabrielle Zhou, carries an average stock price target met ratio of 66.67% that have a potential upside of 29.35% achieved within 102 days. Previously, Gabrielle Zhou worked at MAXIM GROUP.
Gabrielle Zhou’s has documented 15 price targets and ratings displayed on 3 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on BLFS, BioLife Solutions at 19-Sep-2017.
Analyst best performing recommendations are on BGNE (BEIGENE LTD).
The best stock recommendation documented was for BGNE (BEIGENE LTD) at 6/30/2017. The price target of $52 was fulfilled within 3 days with a profit of $7 (15.56%) receiving and performance score of 51.85.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 25-Feb-2019
$260
$75.29 (40.76%)
$254
1 years 1 months 27 days ago
(13-Nov-2024)
5/9 (55.56%)
$64.55 (33.03%)
150
Buy
Since 17-Jul-2023
$288
$103.29 (55.92%)
$285
1 years 5 months 1 days ago
(08-Aug-2024)
0/4 (0%)
$104.97 (57.35%)
Hold
Since 12-Apr-2023
$152.5
$-32.21 (-17.44%)
$164.3
1 years 6 months ago
(09-Jul-2024)
4/4 (100%)
$7.97 (5.51%)
103
Buy
Since 13-Oct-2022
$345
$160.29 (86.78%)
$350
1 years 10 months 13 days ago
(27-Feb-2024)
2/5 (40%)
$165.31 (92.00%)
350
Buy
Since 14-May-2019
$319
$134.29 (72.70%)
$321
2 years 4 months 11 days ago
(29-Aug-2023)
4/10 (40%)
$105.41 (49.35%)
105
What Year was the first public recommendation made by Gabrielle Zhou?